These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31172600)

  • 1. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
    Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T
    J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro.
    Celentano A; Yiannis C; Paolini R; Zhang P; Farah CS; Cirillo N; Yap T; McCullough M
    Sci Rep; 2020 Sep; 10(1):15904. PubMed ID: 32985597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
    Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
    J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
    Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
    J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
    Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
    Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography.
    Cheung C; Baker JD; Byrne JM; Perrault KA
    J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
    Petersen GE; Tang Y; Fields C
    J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Purification of Potent Growth Inhibitors from
    Van TM; Xuan TD; Minh TN; Quan NV
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
    Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
    Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.
    Soares RB; Dinis-Oliveira RJ; Oliveira NG
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kavalactones from Kava (Piper methysticum) root extract as modulators of recombinant human glycine receptors.
    Hegazy NH; Breitinger HG; Breitinger U
    Biol Chem; 2019 Aug; 400(9):1205-1215. PubMed ID: 31141476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.
    Folmer F; Blasius R; Morceau F; Tabudravu J; Dicato M; Jaspars M; Diederich M
    Biochem Pharmacol; 2006 Apr; 71(8):1206-18. PubMed ID: 16464438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of kava constituents in an in vitro model of oral mucositis.
    Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
    Tugcu G; Kırmızıbekmez H; Aydın A
    Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.
    Xuan TD; Fukuta M; Wei AC; Elzaawely AA; Khanh TD; Tawata S
    J Nat Med; 2008 Apr; 62(2):188-94. PubMed ID: 18404321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive effects of kava (Piper methysticum): a systematic review.
    LaPorte E; Sarris J; Stough C; Scholey A
    Hum Psychopharmacol; 2011 Mar; 26(2):102-11. PubMed ID: 21437989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (
    Wang Y; Su C; Zhang B; Niu Y; Ren R; Zhao X; Yang L; Zhang W; Ma X
    Evid Based Complement Alternat Med; 2021; 2021():6851798. PubMed ID: 34471418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.